Senior insider sale
CEO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$2.13M
56.24K shares
What this filing means
PIMSTONE SIMON N. plans to sell 56.24K shares of XENON PHARMACEUTICALS INC. valued at approximately $2.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/30/2023ACC: 0000950170-23-025011
DirectorOfficer· CEO
Since Sep 2019
56.24K
Shares to sell
$2.13M
Approx. market value
37.01K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of options
Net exercise
3/7/2023
37.01KTotal acquired37.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/7/2023 | Exercise of options Net exercise | 37.01K | — |
| Total | 37.01K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
19.23K
Market value
$711.2K
3/7/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
37.01K
Market value
$1.42M
5/30/2023
Total
Units
56.24K
Value
$2.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/7/2023 | 19.23K | $711.2K | — | Completed |
| Planned — Approximate Date | ||||
5/30/2023 | 37.01K | $1.42M | NASDAQ | Planned |
| Total | 56.24K | $2.13M | ||